NASDAQ:BRNS | Income Statement | Barinthus Biotherapeutics plc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$3.92M$11.02M-$11.02M$397,000.00-$10.62M-$23,000.00-$10.58M-$0.26-$0.2640,848,89340,848,893
2026-03-31$3.59M$6.12M-$6.08M$525,000.00-$5.55M-$16,000.00-$5.53M-$0.14-$0.1440,848,89340,848,893
2025-12-31$0.00$3.93M$11.57M-$11.57M$405,000.00-$11.16M-$57,000.00-$11.09M-$0.27-$0.27102,483102,483
2025-09-30$0.00$5.39M$15.22M-$15.07M$424,000.00-$14.64M-$71,000.00-$14.57M-$0.36-$0.3640,661,11840,661,118
2025-06-30$7.95M$23.34M-$23.32M$2.17M-$21.15M-$25,000.00-$21.12M-$0.52-$0.5240,343,52140,343,521
2025-03-31$8.29M$20.93M-$20.6M$920,000.00-$19.68M-$22,000.00-$19.65M-$0.49-$0.4940,265,21640,265,216
2024-12-31$0.00$8.31M$23.57M-$23.39M$2.8M-$20.59M$3,000.00-$20.54M-$0.51-$0.51268,981268,981
2024-09-30$14.97M$11.14M$24.56M-$9.38M$1.25M-$8.13M-$3,000.00-$8.11M-$0.21-$0.2139,419,44739,419,447
2024-06-30$0.00$11.66M$18.86M-$18.29M$1.34M-$16.95M-$7,000.00-$16.93M-$0.43-$0.4339,041,11139,041,111
2024-03-31$0.00$11.13M$17.12M-$16.91M$1.36M-$15.56M-$37,000.00-$15.49M-$0.40-$0.4038,773,48238,773,482
2023-12-31$0.00$6.37M$19.99M-$19.99M$1.88M-$18.11M-$820,000.00-$17.29M-$0.45-$0.4566,28366,283
2023-09-30$0.00$15.14M$16.11M-$16.11M$1.39M-$14.71M-$603,000.00-$14.07M-$0.37-$0.3738,533,83338,533,833
2023-06-30$334,000.00$13.54M$26.67M-$26.34M$1.38M-$24.96M-$1.14M-$23.8M-$0.62-$0.6238,407,67238,407,672
2023-03-31$468,000.00$9.81M$21.95M-$21.48M$2.75M-$18.74M-$516,000.00-$18.18M-$0.48-$0.4838,013,39938,013,399
2022-12-31$6.46M$12.19M$31.55M-$25.09M$1.91M-$23.18M-$2.02M-$21.19M-$0.57-$0.5534,339-56,785
2022-09-30$6.17M$9.74M-$1.07M$7.24M$311,000.00$7.55M-$674,000.00$8.24M$0.22$0.2237,247,12338,156,564
2022-06-30$17.06M$9.72M$3.83M$13.24M$1.54M$14.77M-$915,000.00$15.69M$0.42$0.4137,202,60038,174,426
2022-03-31$15.02M$10.7M$14.36M$654,000.00$1.06M$1.71M-$863,000.00$2.6M$0.07$0.06837,191,02238,346,668
2021-12-31-$1,000.00$6.88M$16.67M-$16.67M$1.53M$32,000.00-$15.11M-$0.38-$0.383,196,9133,196,913
2021-09-30$19,000.00$4.37M$5.56M-$5.54M$959,000.00-$7,000.00-$4.56M-$0.13-$0.1334,843,15434,843,154
2021-06-30$35,000.00$4.51M$16.88M-$16.85M$872,000.00$12,000.00-$15.93M-$0.64-$0.6424,897,66524,897,665
2021-03-31$215,000.00$4.61M$6.39M-$6.17M-$9.28M-$65,000.00-$15.27M-$1.90-$1.908,057,2168,057,216
2020-12-31$354,000.00$2.57M$9.99M-$9.63M-$797,000.00-$10.46M-$1.32-$1.3218,04118,041
2020-09-30$3.25M$3.7M$4.68M-$1.43M$1.63M$158,000.00$0.02$0.017,937,38415,867,533
2020-06-30$511,000.00$3.88M$4.85M-$4.34M$679,000.00-$3.59M7,904,838
2020-03-31$705,000.00$4.24M$5.35M-$4.65M$698,000.00-$3.82M7,816,681

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$0.00$25.56M$71.06M-$70.56M$3.92M-$66.63M-$175,000.00-$66.43M-$1.64-$1.6440,527,21840,527,218
2024-12-31$14.97M$42.24M$84.12M-$67.97M$6.74M-$61.23M-$44,000.00-$61.07M-$1.55-$1.5539,348,24039,348,240
2023-12-31$802,000.00$44.87M$84.72M-$83.91M$7.39M-$76.52M-$3.08M-$73.35M-$1.91-$1.9138,386,49138,386,491
2022-12-31$44.7M$42.35M$48.74M-$4.04M$4.89M$850,000.00-$4.47M$5.34M$0.14$0.1437,248,12638,169,307
2021-12-31$268,000.00$20.37M$45.49M-$45.22M-$5.92M-$51.14M-$28,000.00-$50.87M-$1.96-$1.9625,894,37525,894,375
2020-12-31$4.82M$14.39M$24.87M-$20.05M$2.21M$95,000.00-$17.71M-$2.24-$2.247,904,5297,904,529